Transitioning Stable Patients with Pulmonary Arterial Hypertension from Parenteral Prostanoids to Oral Selexipag.

Hinkamp, Colin; Bartolome, Sonja; Mims, Edward; Chin, Kelly; Shah, Trushil

Hinkamp, Colin; Bartolome, Sonja; Mims, Edward; Chin, Kelly; Shah, Trushil.

Afiliação

Hinkamp C; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Bartolome S; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Mims E; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Chin K; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Shah T; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Biomed Hub ; 7(3): 115-124, 2022.

Article em En | MEDLINE | ID: mdl-36465803

Palavras-chave

Prostacyclin; Prostaglandins; Pulmonary arterial hypertension; Pulmonary hypertension; Six-minute walk distance

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Biomed Hub Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google